| NCT01320436 | Sheba Medical Center | Ulcerative Colitis | 2011-07 | PHASE3 |
| NCT00069498 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 1999-10 | PHASE1 |
| NCT00652145 | James Lewis|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Shire | Ulcerative Colitis | 2008-09 | PHASE4 |
| NCT01120340 | SOFAR S.p.A. | Diverticular Disease | 2005-10 | PHASE3 |
| NCT00194818 | University of Washington|Procter and Gamble | Ulcerative Colitis | 2003-06 | PHASE4 |
| NCT04920149 | Ann-Sofie Backman|The Swedish Research Council|Karolinska Institutet | Lynch Syndrome|Colon Cancer|Colon Neoplasm | 2022-03-21 | PHASE2 |
| NCT01130844 | Shire | Ulcerative Colitis | 2010-10-08 | PHASE1 |
| NCT02910245 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|ZonMw: The Netherlands Organisation for Health Research and Development | Colitis, Ulcerative | 2016-11 | PHASE3 |
| NCT01841099 | Kelsey Jones|Imperial College London | Malnutrition | 2013-06 | PHASE1|PHASE2 |
| NCT00840203 | Teva Pharmaceuticals USA | Healthy | 2003-05 | PHASE1 |
| NCT05986136 | Mostafa Bahaa | Inflammatory Bowel Diseases | 2023-08-20 | PHASE2|PHASE3 |
| NCT01327300 | University of Florida | Irritable Bowel Syndrome | 2010-03 | PHASE2 |
| NCT01177410 | Bausch Health Americas, Inc. | Irritable Bowel Syndrome With Diarrhea | 2010-07 | PHASE2 |
| NCT07349472 | Ihab Elsayed Hassan | Inflammatory Bowel Diseases | 2026-01-20 | PHASE2 |
| NCT05488405 | Dr. Falk Pharma GmbH | Eosinophilic Esophagitis | 2023-02-09 | PHASE2 |
| NCT00245505 | Ferring Pharmaceuticals | Crohn´s Disease | 2009-02 | PHASE3 |
| NCT02522780 | Ferring Pharmaceuticals | Ulcerative Colitis | 2016-02-01 | PHASE3 |
| NCT00744016 | Bausch Health Americas, Inc. | Ulcerative Colitis | 2004-12 | PHASE3 |
| NCT05781698 | Tanta University|Manal Ali Mahrous Hamouda Faculty of Pharmacy, Menufia University | Inflammatory Bowel Diseases | 2023-03-20 | PHASE2 |
| NCT00326209 | Bausch Health Americas, Inc. | Ulcerative Colitis | 2005-12-22 | PHASE3 |
| NCT02522767 | Ferring Pharmaceuticals | Ulcerative Colitis | 2015-10 | PHASE3 |
| NCT00554099 | Warner Chilcott | Diverticulitis | 2007-11 | PHASE2 |
| NCT00767728 | Bausch Health Americas, Inc. | Ulcerative Colitis | 2004-12 | PHASE3 |
| NCT07064707 | Alexandria University|Prof. Dr. Ahmed Ibrahim Mohammed El Mallah, faculty of pharmacy, Alexandria University.|Assoc. Prof. Dr. Noha Alaa Eldin Hassan Hamdy, Faculty of pharmacy, Alexandria University.|Assoc. Prof. Dr. Ibrahim Fathi Amer, Faculty of Medecine, Kafr Elsheikh University. | Ulcerative Colitis | 2025-07-15 | PHASE2 |
| NCT05316220 | AbbVie | Ulcerative Colitis (UC) | 2025-09-15 | PHASE3 |
| NCT00254618 | Warner Chilcott | Ulcerative Colitis | 2005-10 | PHASE1 |
| NCT01586533 | Altheus Therapeutics, Inc. | Ulcerative Colitis|Left-sided Ulcerative Colitis|Distal Ulcerative Colitis | 2012-06 | PHASE2 |
| NCT01412372 | University of Utah|Shire Human Genetic Therapies, Inc. | Irritable Bowel Syndrome | 2010-06 | PHASE3 |
| NCT00802451 | Padagis LLC | Healthy | 2003-02 | NA |
| NCT05988528 | Mostafa Bahaa | Inflammatory Bowel Diseases | 2023-08-20 | PHASE2|PHASE3 |
| NCT00746447 | Dr. Falk Pharma GmbH | Colitis, Ulcerative|Recurrence | 2005-05 | PHASE3 |
| NCT03070574 | Christoph Gasche|Prof. Dr. Gabriela M?slein, Germany|Prof. Dr. Hans Vasen, The Netherlands|Prof. Dr. med. Jan Lubinski, Poland|Prof. Dr. med. Yaron Niv, Israel|Univ. Prof. Dr. Judith Karner-Hanusch, Austria|Ann-Sofie Backman, MD PhD, Sweden | Colorectal Cancer | 2017-11-24 | PHASE2 |
| NCT02125292 | Shire | Healthy | 2014-06-02 | PHASE1 |
| NCT05663775 | AHS Cancer Control Alberta | Immune-related Adverse Event|Diarrhea|Advanced Melanoma|Advanced Rectal Carcinoma | 2024-08-20 | PHASE2 |
| NCT01696942 | Milton S. Hershey Medical Center|UCB Pharma | Crohn´s Disease | 2013-02 | PHASE4 |
| NCT05567068 | Tanta University | Inflammatory Bowel Diseases | 2023-02-01 | PHASE2 |
| NCT01999400 | University of Michigan|Food and Drug Administration (FDA) | Local Drug Concentration in Gastrointestinal Tract | 2012-04 | NA |
| NCT00505778 | Warner Chilcott | Ulcerative Colitis | 2007-07 | PHASE3 |
| NCT01172444 | Sandoz | Proctitis | 2010-06 | PHASE3 |
| NCT01090102 | University of California, San Francisco|California HIV+AIDS Research Program|Bausch Health Americas, Inc. | HIV Infections|Sexually Transmitted Diseases|Immune System Diseases|Lentivirus Infections|Acquired Immunodeficiency Syndrome | 2010-06 | PHASE4 |
| NCT03415711 | VSL Pharmaceuticals|Actial Farmaceutica S.r.l. | Ulcerative Colitis | 2017-04-28 | NA |
| NCT00343850 | University of Chicago|Procter and Gamble | Ulcerative Colitis | 2006-09 | PHASE3 |
| NCT01045018 | EMET Pharmaceuticals, LLC|Eagle Pharmaceuticals, Inc. | Mild to Moderate Ulcerative Colitis | 2008-01 | PHASE3 |
| NCT05753267 | Tanta University|Hend El-Said Abo Mansour, Faculty of Pharmacy, Menoufia University|Monir Hussein Bahgat, Faculty of Medicine, Mansura University | Inflammatory Bowel Diseases | 2023-02-28 | PHASE2|PHASE3 |
| NCT00514982 | National Institute of Allergy and Infectious Diseases (NIAID) | Hermanski-Pudlak Syndrome|Colitis|Cytokines|Lymphocytes|Drug Evaluation | 2007-08-07 | PHASE2 |
| NCT06625450 | Post Graduate Institute of Medical Education and Research, Chandigarh | Ulcerative Colitis | 2024-10 | PHASE4 |
| NCT01088243 | National Jewish Health | Chronic Beryllium Disease | 2010-03 | PHASE1|PHASE2 |
| NCT00350415 | Warner Chilcott | Ulcerative Colitis | 2006-06 | PHASE3 |
| NCT06525974 | Tanta University | Ulcerative Colitis | 2024-09-01 | EARLY_PHASE1 |
| NCT05119140 | Icahn School of Medicine at Mount Sinai|Crohn´s and Colitis Foundation | Ulcerative Colitis (Disorder) | 2022-06-10 | PHASE1|PHASE2 |
| NCT01789294 | Azienda Policlinico Umberto I | Intestinal LNH | 2008-11 | PHASE4 |
| NCT01201122 | Wolfson Medical Center | Mild to Moderate Ulcerative Colitis | 2010-09 | PHASE4 |
| NCT00622375 | Bausch Health Americas, Inc. | Healthy | 2008-02 | PHASE1 |
| NCT07333716 | Tanta University | Ulcerative Colitis (UC)|Ulcerative Colitis | 2026-01-26 | PHASE2 |
| NCT00073021 | Warner Chilcott | Ulcerative Colitis | 2000-09 | PHASE3 |
| NCT07180186 | Tanta University | Microbiota|Probiotic Therapy|Ulcerative Colitis | 2022-01-01 | |
| NCT00446849 | Shire | Ulcerative Colitis | 2007-05-01 | PHASE4 |
| NCT03716388 | Dayanand Medical College and Hospital|Colitis & Crohn´s Foundation (India) | Ulcerative Colitis Chronic Mild|Ulcerative Colitis Chronic Moderate | 2018-12-01 | PHASE3 |
| NCT02280629 | Dr. Falk Pharma GmbH | Ulcerative Colitis | 2014-10-01 | PHASE3 |
| NCT01020708 | Altheus Therapeutics, Inc. | Ulcerative Colitis | 2009-11 | PHASE1 |
| NCT00577473 | Warner Chilcott | Ulcerative Colitis | 2001-02 | PHASE3 |
| NCT01209208 | Dr. Falk Pharma GmbH | Lymphocytic Colitis | 2010-05 | PHASE3 |
| NCT06993974 | Alexandria University|Prof. Dr. Ahmed Ibrahim Mohammed El Mallah, faculty of pharmacy, Alexandria University.|Assoc. Prof. Dr. Noha Alaa Eldin Hassan Hamdy, Faculty of pharmacy, Alexandria University.|Assoc. Prof. Dr. Ibrahim Fathi Amer, Faculty of Medecine, Kafr Elsheikh University. | Ulcerative Colitis | 2025-05-30 | PHASE2 |
| NCT01627262 | Dr. Falk Pharma GmbH | Colonic Diverticulosis | 2002-05 | PHASE2 |
| NCT06213857 | Tanta University | Ulcerative Colitis | 2025-02-01 | PHASE2 |
| NCT00952952 | Mayo Clinic|Paul E. Evans MD|William J. Sandborn MD|Edward V. Loftus MD|Thomas C. Smryk MD|Willaim Tremaine MD | Microscopic Colitis|Diarrhea | 2007-02 | PHASE2|PHASE3 |
| NCT01534312 | University of Aarhus|Arla Foods | Colitis, Ulcerative|Inflammatory Bowel Diseases | 2012-01 | NA |
| NCT06878495 | Pusan National University Hospital | Ulcerative Colitis (UC)|Crohn's Disease|Inflammatory Bowel Disease (IBD) | 2025-06-15 | NA |
| NCT02665845 | Centre Hospitalier Universitaire de Saint Etienne | Ulcerative Colitis | 2016-06-13 | PHASE3 |
| NCT06998693 | Xijing Hospital of Digestive Diseases | Ul | 2024-08-01 | |
| NCT01532648 | Bausch Health Americas, Inc. | Ulcerative Colitis | 2012-01-27 | PHASE3 |
| NCT03804931 | Guangzhou First People´s Hospital | Ulcerative Colitis|Fecal Microbiota Transplantation | 2019-01-20 | PHASE2|PHASE3 |
| NCT01038739 | Dr. Falk Pharma GmbH | Diverticulitis | 2010-01 | PHASE3 |
| NCT00774007 | SOFAR S.p.A.|IRCCS Azienda Ospedaliero-Universitaria di Bologna | Irritable Bowel Syndrome | 2004-09 | PHASE2|PHASE3 |
| NCT01124149 | Shire | Ulcerative Colitis | 2010-06-29 | PHASE4 |
| NCT02537210 | Chinese University of Hong Kong|Queen Elizabeth Hospital, Hong Kong|Alice Ho Miu Ling Nethersole Hospital|Tseung Kwan O Hospital, Hong Kong | Colitis, Ulcerative|Aminosalicylic Acid | 2015-09 | NA |
| NCT01534754 | Hospital Cristo Re | Diverticular Disease of the Colon | 2009-01 | PHASE4 |
| NCT02368743 | Ferring Pharmaceuticals | Distal Ulcerative Colitis | 2015-12 | |
| NCT06568224 | The First Affiliated Hospital with Nanjing Medical University | Hidradenitis Suppurativa | 2020-05-01 | |
| NCT00708656 | Cardiff and Vale University Health Board|Procter and Gamble | Ulcerative Colitis | 2006-10 | PHASE3 |
| NCT02077777 | SOFAR S.p.A. | Colorectal Cancer | 2012-10 | PHASE2 |
| NCT05538026 | Bogomolets National Medical University|Ukrainian Research and Practical Centre of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine | Ulcerative Colitis Chronic Mild|Inflammatory Bowel Diseases | 2020-09-01 | NA |
| NCT01831323 | S.Eugenio Hospital | Simple Diverticular Disease | 2012-12 | |
| NCT04133194 | Flemming Bendtsen | Ulcerative Colitis | 2019-11-28 | PHASE4 |
| NCT00545103 | Shire | Diverticulitis | 2007-12-06 | PHASE3 |
| NCT01257399 | Tillotts Pharma AG|Zeria Pharmaceutical | Ulcerative Colitis in Remission | 2010-11 | PHASE3 |
| NCT00695643 | Dr. Falk Pharma GmbH | Diverticulitis | 2008-01 | PHASE3 |
| NCT02335281 | Yanling Wei | Inflammatory Bowel Disease|Ulcerative Colitis|Crohn´s Disease | 2015-01 | PHASE2 |
| NCT01257386 | Tillotts Pharma AG|Zeria Pharmaceutical | Active Ulcerative Colitis | 2010-11 | PHASE3 |
| NCT00548574 | Shire | Ulcerative Colitis | 2003-12-04 | PHASE3 |
| NCT00737789 | Ferring Pharmaceuticals | Ulcerative Colitis | 2008-11 | PHASE3 |
| NCT02368717 | Ferring Pharmaceuticals | Ulcerative Colitis | 2015-03 | PHASE3 |
| NCT05912712 | Xijing Hospital of Digestive Diseases | Ulcerative Colitis Chronic Moderate|Ulcerative Colitis Chronic Severe|Rectal Ulcer | 2023-07-01 | PHASE1 |
| NCT00450086 | Dr. Falk Pharma GmbH | Collagenous Colitis | 2007-03 | PHASE3 |
| NCT03441893 | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | Ulcerative Colitis|Ulcerative Colitis Exacerbation|Protozoan Infections|Helminth Infection | 2015-01-01 | PHASE1|PHASE2 |
| NCT00808977 | Palau Pharma S.L.U. | Ulcerative Colitis | 2008-12 | PHASE2 |
| NCT01745770 | Dr. Falk Pharma GmbH | Active Ulcerative Colitis | 2013-01 | PHASE3 |
| NCT03110198 | Xijing Hospital of Digestive Diseases|Shanghai Tongji Hospital, Tongji University School of Medicine|First Affiliated Hospital of Zhongshan Medical University | Ulcerative Colitis, Unspecified | 2017-05 | PHASE4 |
| NCT00626288 | SOFAR S.p.A. | Irritable Bowel Syndrome | 2007-12 | PHASE3 |
| NCT02044952 | Zhu Weiming | Inflammatory Bowel Diseases|Crohn´s Disease|Gastrointestinal Diseases|Digestive System Diseases|Intestinal Diseases | 2014-01 | PHASE2|PHASE3 |
| NCT00747110 | Dr. Falk Pharma GmbH | Colitis, Ulcerative | 2007-10 | PHASE3 |
| NCT01966783 | Dr. Falk Pharma GmbH | Proctitis | 2013-09 | PHASE2 |
| NCT03104036 | Institute for Clinical and Experimental Medicine|Institute of Animal Physiology and Genetics Academy of Science Czech Republic | Ulcerative Colitis | 2017-06-19 | PHASE2 |
| NCT02769494 | Xijing Hospital of Digestive Diseases | Crohn´s Disease|Oral Ulcer | 2016-03 | PHASE3 |
| NCT05780723 | Beijing Hospital of Traditional Chinese Medicine | Ulcerative Colitis | 2023-04-04 | NA |
| NCT07389824 | Qin Yu | Ulcerative Colitis | 2026-02-01 | NA |
| NCT01894685 | UMC Utrecht | Sporadic Colorectal Adenoma | 2012-07 | PHASE2 |
| NCT00545389 | Shire | Colitis, Ulcerative | 2003-02-10 | PHASE2 |
| NCT03412682 | Ferring Pharmaceuticals | Colitis, Ulcerative | 2018-03-02 | PHASE3 |
| NCT05205603 | Sixth Affiliated Hospital, Sun Yat-sen University | Ulcerative Colitis|Efficacy, Self|Biologics|Mesalazine | 2022-01-15 | PHASE4 |
| NCT01514240 | AstraZeneca | Crohn´s Disease | 2012-02 | PHASE3 |
| NCT00663247 | University of Nottingham | Diverticulosis, Colonic | 2008-04 | NA |
| NCT01316718 | University of Nottingham|National Institute for Health Research, United Kingdom | Irritable Bowel Syndrome With Diarrhoea | 2011-03 | PHASE4 |
| NCT06176560 | Faes Farma, S.A. | Colitis, Ulcerative | 2024-03 | PHASE3 |
| NCT06201793 | Mostafa Bahaa|Amira Fawzy Mohamed Mashaly, Clinical Pharmacy Demonstrator, Faculty of Pharmacy- Horus University|Tanta University|Mounir Hussein Bahgat Internal Medicine Department Mansoura University | Inflammatory Bowel Diseases | 2024-01-22 | PHASE2 |
| NCT00300118 | Dr. Falk Pharma GmbH | Crohn´s Disease | 2004-09 | PHASE3 |
| NCT03917095 | The Second Hospital of Nanjing Medical University | Ulcerative Colitis Chronic Mild|Ulcerative Colitis Chronic Moderate | 2019-05-15 | NA |
| NCT01517607 | Ferring Pharmaceuticals|Ferring Arzneimittel GmbH | Ulcerative Colitis | 2012-02 | |
| NCT00976690 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Crohn Disease | 2002-10 | PHASE3 |
| NCT00151944 | Shire | Colitis, Ulcerative | 2003-11-26 | PHASE3 |
| NCT02261636 | Ferring Pharmaceuticals | Ulcerative Colitis | 2015-01 | |
| NCT00503243 | Shire | Colitis, Ulcerative | 2003-09-30 | PHASE3 |
| NCT00449722 | Dr. Falk Pharma GmbH | Ulcerative Colitis | 2005-07 | PHASE3 |
| NCT01536535 | Connecticut Children´s Medical Center|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Ulcerative Colitis | 2012-07-10 | PHASE4 |
| NCT00946946 | Dr. Falk Pharma GmbH | Crohn´s Disease | 2002-02 | PHASE3 |
| NCT01699438 | Hans T?rnblom|Sahlgrenska University Hospital|Smerud Medical Research International AS|Alimenta AB|Tillotts Pharma AG|Karolinska University Hospital|Haukeland University Hospital|Oslo University Hospital|Sykehuset Innlandet HF | Irritable Bowel Syndrome | 2012-04 | PHASE2 |
| NCT00167882 | Amsterdam UMC, location VUmc | Crohn´s Disease|Ulcerative Colitis|Inflammatory Bowel Disease | 2005-07 | PHASE4 |
| NCT00603733 | Ferring Pharmaceuticals | Active Ulcerative Colitis|Remission of Ulcerative Colitis | 2007-10 | PHASE3 |
| NCT02331823 | Shanghai Pulmonary Hospital, Shanghai, China|Shanghai Center for Disease Control and Prevention|Jiangsu Province Centers for Disease Control and Prevention|Zhejiang University|Centers for Disease Control and Prevention | Reinfection Pulmonary Tuberculosis | 2013-06 | PHASE4 |